sur BioRiver E.V.
11th BioRiver Boost: Celebrating Innovation in Biotechnology
The 11th BioRiver Boost competition has announced its winners for 2024. Ingineeon, a Munich-based firm specializing in cytokine-based immunotherapies, secured the first place. Their innovative approach targets cancer, infectious diseases, and autoimmune disorders.
Second place went to Berlin's TCBalance Biopharmaceuticals GmbH, which develops therapies based on regulatory T cells to address chronic diseases. Bonn's Sweethoven Biotech, known for creating a sustainable sweet-tasting fiber, took third place.
A special prize was awarded to TumiKo, an Essen-based start-up, giving them a guaranteed finalist position in next year's competition.
BioRiver Boost, organized by BioRiver e.V., offers crucial support and networking opportunities for young life science companies. The competition was judged by executives from prominent global life science firms and financiers.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BioRiver E.V.